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Associations between low back pain, disability,
functional status, and serum interleukin-1 β level
Aim: In the past the role of biochemical mediators of inflammation in back pain received little
attention. The purpose of the present study was to examine the association between serum IL-1 β level
in patients with low back pain (LBP) and its effect on their functional status.
Methods: This cross-sectional study included 88 LBP patients with symptom duration of 6 months
or longer and 65 healthy controls. Serum analysis was performed using ELISA. The LBP group
completed the Roland-Morris Disability Questionnaire and Oswestry Disability Index in order to
evaluate their functional status.
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Results: Mean IL-1 β level was significantly higher in the LBP group than in the control group. As
the duration of LBP and age increased, IL-1 β level also increased significantly. We observed a positive
correlation between IL-1 β level and Oswestry Disability Index score.
Conclusion: Proinflammatory cytokine levels, including IL-l β, were elevated in LBP patients, which
affected their functional status. Determination of the influence of cytokines in LBP may aid in
improving diagnostic and therapeutic interventions for LBP.
Key words: Low back pain, interleukin-1 β, functional status

Bel ağrılı olgularda, sakatlık, fonksiyonel durum ile
Il-1 β düzeyinin karşılaştırılması
Amaç: Bel ağrısındaki inflamasyon ve bu inflamasyona yol açan mediatörlerin rolünün araştırılması
güncelliğini korumaktadır. Bu çalışmada temel proinflamatuar mediatörlerden olan interlökin-1β’in
bel ağrısı ve yaşam kalitesi ile olan ilişkisi araştırılmıştır.
Yöntemler: Altı aydan daha uzun süreli bel ağrısı yakınması olan 88 hasta ve sağlıklı 65 kontrol
çalışmaya alındı. Çalışmaya katılan tüm bireylerin serum IL-1 β düzeyleri ELISA yöntemi
kullanılarak ölçüldü. Bel ağrısı olan gruba Oswestry ve Roland-Morris disabilite ölçekleri uygulandı.
Bulgular: IL-1 β düzeyleri bel ağrılı olgularda anlamlı yüksek bulunmuştur. Bel ağrısın süresi ve
hasta yaşı arttıkça serum IL-1 β düzeyi anlamlı olarak artmaktaydı. Serum IL-1 β düzeyi ile Oswestry
Disabilite Indeksi arasında pozitif korelasyon saptandı.
Received: November 22, 2007
Accepted: January 12, 2009

Sonuç: Çalışmamızın sonuçlarına göre, bel ağrılı olgularda IL-1 β vb gibi proinflamatuar sitokinlerin
serum düzeyi artmıştır ve bu durum hastanın fonksiyonel durumunu etkilemektedir. Sitokinlerin
bel ağrısındaki yerinin belirlenmesi, bu hastalığın tanı ve tedavisinde yeni gelişmelere yol açacaktır.
Anahtar sözcükler: Bel ağrısı, interlökin 1 β, fonksiyonel durum
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Introduction
Low back pain (LBP) is a significant clinical entity that causes major disability.
Although the etiology and the exact pathophysiology of LBP remain elusive,
environmental and genetic factors may play significant roles (1,2).
The biochemical events that occur as a result of intervertebral disk degeneration
and, in particular, the role of biochemical mediators of inflammation and tissue
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degradation have received little attention in the
literature (1-3).

of these kits is 3.9-250 pg/mL and the sensitivity is 1
pg/mL (7).

Interleukin 1 beta (IL-1 β), a proinflammatory
cytokine, contributes to joint degeneration by
inducing enzymes that destroy proteoglycan and is
involved in the mediation of pain (4-6). The
production of IL-1 β might be influenced by the
potential risk factors for LBP (2).

Functional health status of the patients was
evaluated with the Roland-Morris Disability
Questionnaire, a disease-specific instrument, and
their psychosocial variables were measured using the
Oswestry Disability Index, a questionnaire with 10
sections, including pain intensity, self-care, and the
ability to sit, stand, sleep, walk, lift, travel, or
participate in social events (8,9). The Roland-Morris
score was calculated by simply summing the scores.

The purpose of the present study was to examine
the association between serum IL-1 β level in LBP
patients and its effect on their functional status.
Materials and methods
The study was conducted at the Department of
Physical Medicine and Rehabilitation, Gaziantep
University Medical School, and included 88 LBP
patients (40 male, 48 female) with symptom duration
of 6 months or longer. The control group included 65
age- and sex-matched healthy subjects.
The LBP patients were sub-grouped as mechanical
back pain, spinal stenosis, lumbar disc herniation, and
facet syndrome, on the basis of patient history,
physical examination, laboratory investigation (whole
blood count and erythrocyte sedimentation rate,
calcium, phosphorus, and alkaline phosphatase levels,
and urinary analysis), and imaging techniques, such
as CT and/or MRI, when needed. Patients that
experienced recent low back trauma, were pregnant,
or had cauda equina symptoms and/or co-existent
diseases, such as cancer, osteoporosis, and rheumatic
disease, were excluded from the study.
Among the 88 LBP patients, 30 had
musculotendinous strain findings in the lumbar
region based on physical examination, but no
radiculopathy. Patients whose radiographs revealed
mechanical disorders, such as summarization,
sacralization, and reduction in the lumbosacral angle,
were diagnosed with mechanical LBP. In all, 13
patients were diagnosed with facet syndrome, 22
patients with spinal stenosis, and 23 with lumbar disk
herniation, based on physical examination, and MRI
or CT findings.
Serum IL-1 β level in the patient and control
groups was measured using KHC0011C ELISA kits
obtained from Biosource International, Inc. The range
614

The Oswestry disability questionnaire consists of
10 items that focus on different aspects of functioning.
Each item is scored from 0 to 5, with higher values
indicating greater disability. Total score is multiplied
by 2 and expressed as a percentage. A score of 0%-20%
indicates a baseline level or minimal disability, 21%40% indicates moderate disability, 41%-60% indicates
severe disability, 61%-80% indicates crippled, and
81%-100% indicates bedridden or exaggeration of
symptoms (10). Evaluations were performed using the
criteria described above.
Statistical analyses were performed using SPSS
v.13.0. The chi-square test was used to analyze
demographic data, diagnoses, questionnaires, and ILl β levels. An ANOVA model was used to compare
age, disease duration, and questionnaire scores with
IL-1 β levels. To assess IL-l β levels between groups,
Student’s t-test was used.
Results
Demographic data of the participants are shown
in Table 1. Roland-Morris Disability Questionnaire
and Oswestry Disability Index scores, and serum IL1 β levels are shown in Table 2. There were no
significant differences between groups in terms of age,
Table 1. Patient demographic data.
LBP group

Control group

P

Age

43.5 (23-69)

41.2 (24-62)

0.350

Gender

40 men
48 women

32 men
39 women

0.90

28.4

26.6

0.089

BMI
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Table 2. Mean (range) Roland-Morris Disability Questionnaire
and Oswestry Disability Index scores, and serum IL-1 β
levels.
LBP group

Control group

P

IL-1β level

77.3 (57-160)

34.5 (18-74)

0.001

Roland-Morris score

14.2 (9-22)

-----

Oswestry score

66.8 (48-78)

-----

gender, or BMI. The difference between serum IL-1 β
levels in the patient and control groups was significant
(P = 0.001). In the patient group a significant positive
correlation was observed between IL-l β level, and
both LBP duration and age (r = 0.480 and r = 0.340,
respectively). We also observed a positive correlation
between serum IL-1 β level and Oswestry Disability
Index score (P = 0.024; r = 0.241) in the LBP group;
however, there was no relationship between serum IL1 β level and Roland-Morris Disability Questionnaire
score (P = 0.069; r = 0.195). A significant relationship
between age, and both Roland-Morris and Oswestry
Disability scores (P = 0.767 and P = 0.970,
respectively) was not observed in the LBP group.
Moreover, a significant relationship was not observed
between gender of the LBP patients, and LBP
syndromes and IL-l β level (P = 0.341). There was no
relationship between the duration of back pain, and
Roland-Morris Disability Questionnaire or Oswestry
Disability Index scores (P = 0.248 and P = 0.506,
respectively).
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There were positive correlations between serum
IL-1 β level and the following sub-groups of LBP
patients: spinal stenosis, facet syndrome, disk hernia,
and mechanical back pain (P = 0.012). When the
patients with spinal stenosis, facet syndrome, and disk
hernia were excluded one by one from the
comparison the statistical significance remained (P =
0.014, 0.017, and 0.016, respectively), whereas when
mechanical back pain patients were excluded from the
comparison statistical significance disappeared (P =
0.18).
Serum IL-l β levels in the LBP patient and control
groups are presented in Figure 1. The relationships
between diagnostic parameters and serum IL-1 β level
are shown in Figure 2.
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Figure 2. Mean IL-1ß levels in LBP patients.
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Figure 1. Mean serum IL-1ß levels in patients and controls.
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Discussion
LBP is a common condition and researchers
suggest that long-term patients continue to have
significant activity limitations and diminished
functional status (7,11,12). There is increasing
evidence implicating cytokines, growth factors, and
inflammatory mediators in the pathogenesis of LBP.
The cytokines IL-1 β and TNF-α are overexpressed in
degenerated intervertebral disks (IVDs), and this
leads to matrix degradation and, subsequently, LBP
(13-16). Le Maitre et al. reported that IL-1 and its
receptor are significantly up-regulated in IVD
degeneration and are, therefore, more likely to be
major mediators in the processes of IVD degeneration
(17). Kang et al. reported that herniated lumbar disks
that spontaneously release MMP, NO, IL-6, and
prostaglandin E2 increase their production further in
response to IL-1 β (18). They concluded that IL-1
could be a target for therapeutic approaches to inhibit
IVD degeneration and subsequent LBP. Most previous
studies measured increased levels of IL-1 β in facet
syndrome, spinal stenosis, and disk herniation (2,3),
and the present study’s results are similar. In addition
to the above-mentioned low back pain subgroups, we
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also observed a significant difference in IL-1B levels
between the mechanical LBP subgroup and control
subjects.
Mean Oswestry Index (66.8) score in the LBP
group was higher than the baseline level, which might
have been due to a lower threshold of pain perception,
cultural determinants, and genetic factors in Turkey.
Furthermore, the observed positive correlation
between IL-1 β level and Oswestry Index score might
have been due to functional status being affected by
IL-1 β levels. Additionally, some other factors, such as
age and duration of disease, may have affected the
functional status of the LBP patients.
In conclusion, the relationship between serum IL1 β and LBP deserves more attention when
determining the prognosis and therapeutic approach
for LBP patients. To the best of our knowledge the
present study is the first to examine IL-1 β and its
effect on the functional status of LBP patients.
Additional research is needed in order to better
elucidate the relationship between inflammatory
cytokines, LBP, and the functional status of LBP
patients.
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